O'Brien V, Grindlay G J, Campo M S
Beatson Institute for Cancer Research, CRC Beatson Laboratories, Garscube Estate, Glasgow G61 1BD, Scotland, United Kingdom.
J Biol Chem. 2001 Sep 7;276(36):33861-8. doi: 10.1074/jbc.M100958200. Epub 2001 Jul 11.
The E5/E8 hydrophobic protein of BPV-4 is, at only 42 residues, the smallest transforming protein identified to date. Transformation of NIH-3T3 cells by E5/E8 correlates with up-regulation of both cyclin A-associated kinase activity and, unusually, p27(Kip1) (p27) but does not rely on changes in cyclin E or cyclin E-CDK2 activity. Here we have examined how p27 is prevented from functioning efficiently as a CDK2 inhibitor, and we investigated the mechanisms used to achieve elevated p27 expression in E5/E8 cells. Our results show that normal subcellular targeting of p27 is not subverted in E5/E8 cells, and p27 retains its ability to inhibit both cyclin E-CDK2 and cyclin A-CDK activities upon release from heat-labile complexes. E5/E8 cells also have elevated levels of cyclins D1 and D3, and high levels of nuclear p27 are tolerated because the inhibitor is sequestered within an elevated pool of cyclin D1-CDK4 complexes, a significant portion of which retain kinase activity. In agreement with this, pRB is constitutively hyperphosphorylated in E5/E8 cells in vivo. The increased steady-state level of p27 is achieved largely through an increased rate of protein synthesis and does not rely on changes in p27 mRNA levels or protein half-life. This is the first report of enhanced p27 synthesis as the main mechanism for increasing protein levels in continuously cycling cells. Our results are consistent with a model in which E5/E8 promotes a coordinated elevation of cyclin D1-CDK4 and p27, as well as cyclin A-associated kinase activity, which act in concert to allow continued proliferation in the absence of mitogens.
牛乳头瘤病毒4型(BPV-4)的E5/E8疏水蛋白仅有42个氨基酸残基,是迄今为止发现的最小的转化蛋白。E5/E8对NIH-3T3细胞的转化与细胞周期蛋白A相关激酶活性的上调有关,而且不同寻常的是,还与p27(Kip1)(p27)的上调有关,但不依赖于细胞周期蛋白E或细胞周期蛋白E-CDK2活性的变化。在此,我们研究了p27如何被阻止有效地发挥CDK2抑制剂的作用,并探究了在E5/E8细胞中实现p27表达升高所采用的机制。我们的结果表明,p27在E5/E8细胞中的正常亚细胞定位并未被破坏,并且p27从热不稳定复合物释放后仍保留其抑制细胞周期蛋白E-CDK2和细胞周期蛋白A-CDK活性的能力。E5/E8细胞中细胞周期蛋白D1和D3的水平也升高,并且高水平的核p27能够被耐受,因为该抑制剂被隔离在升高的细胞周期蛋白D1-CDK4复合物池中,其中很大一部分保留激酶活性。与此一致的是,在体内E5/E8细胞中的pRB持续处于高度磷酸化状态。p27稳态水平的升高主要是通过蛋白质合成速率的增加实现的,并不依赖于p27 mRNA水平或蛋白质半衰期的变化。这是首次报道增强p27合成是连续循环细胞中增加蛋白质水平的主要机制。我们的结果与一个模型相符,即E5/E8促进细胞周期蛋白D1-CDK4和p27以及细胞周期蛋白A相关激酶活性的协同升高,它们共同作用以允许在没有有丝分裂原的情况下继续增殖。